Assessment of the endocrine disrupting properties of bisphenol AF: a case study applying the European regulatory criteria and guidance.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Assessment of the endocrine disrupting properties of bisphenol AF: a case study applying the European regulatory criteria and guidance.Published in
Environ Health 2021; 20(1):48PMID
33894771ae974a485f413a2113503eed53cd6c53
10.1186/s12940-021-00731-0
Scopus Count
Collections
Related articles
- Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance.
- Authors: Karolinska Institutet, Institute of Environmental Medicine, Sweden, Escrivá L, Hanberg A, Zilliacus J, Beronius A
- Issue date: 2019 Sep
- A validated search filter for the identification of endocrine disruptors based on the ECHA/EFSA guidance recommendations.
- Authors: Escrivá L, Hessel E, Gustafsson S, van Spronsen R, Svanberg M, Beronius A
- Issue date: 2020 Sep
- Systematic evaluation of the evidence for identification of endocrine disrupting properties of Bisphenol F.
- Authors: Wiklund L, Beronius A
- Issue date: 2022 Jun 30
- Using assessment criteria for pesticides to evaluate the endocrine disrupting potential of non-pesticide chemicals: Case butylparaben.
- Authors: Boberg J, Johansson HKL, Axelstad M, Olsen GPM, Johansen M, Holmboe SA, Andersson AM, Svingen T
- Issue date: 2020 Nov
- Effects of bisphenol analogues on steroidogenic gene expression and hormone synthesis in H295R cells.
- Authors: Feng Y, Jiao Z, Shi J, Li M, Guo Q, Shao B
- Issue date: 2016 Mar